Intercept Pharmaceuticals Inc. (ICPT) announced after the close Tuesday that it priced an underwritten public offering of 1,730,000 shares of its common stock at a price of $33.01 per share.
Intercept Pharmaceuticals gapped open higher Wednesday and is currently up 3.01 at $36.02, with volume at a 6-month high. The stock has climbed to a 2 1/2 month high.
For comments and feedback: editorial@rttnews.com